Inhibition of PhIP mutagenicity by catechins, and by theaflavins and gallate esters

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 389, Issue 2-3, 1997, Pages 167-172

  Apostolides, Zenon ^a   Balentine, Douglas A ^b   Harbowy, Matthew E ^b   Hara, Yukihiko ^c   Weisburger, John H ^d  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNILEVER RESEARCH   (United Kingdom)

^c Mitsui Norin ^*  (Japan)

^d AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

2 Amino 1 methyl 6 phenylimidazo 4,5 b pyridine (PhIP); 2 nitrofluorene (2 NF); Ames test; Black tea; Camellia sinensis; Cancer; Catechin; Epigallocatechin gallate; Green tea; Hterocyclic amine (HCA); Mutagenicity tests; Tea; Theaflavin

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ANTIMUTAGENIC AGENT; CATECHIN; EPIGALLOCATECHIN GALLATE; GALLIC ACID; GALLIC ACID METHYL ESTER; PHENOL DERIVATIVE; TANNIN;

AMES TEST; ARTICLE; CONTROLLED STUDY; METABOLIC ACTIVATION; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; TEA;

EID: 0031001829     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(96)00143-X     Document Type: Article

References (36)

1. Adamson, R.H., J.A. Gustafsson, N. Ito, M. Nagao, T. Sugimura, K. Wakabayashi and Y. Yamazoe (1995) Heterocyclic amines in cooked foods, Proceedings of the 23rd International Symposium of the Princess Takamatsu Cancer Research Fund, Princeton Scientific Publishing Co., Princeton, NJ.
2. Apostolides, Z. and J.H. Weisburger (1995) Screening of tea clones for inhibition of PhIP mutagenicity, Mutation Res., 326, 219-225.
3. Apostolides, Z., D.A. Balantine, M.E. Harbowy and J.H. Weisburger (1996) Inhibition of PhIP mutagenicity by black and green tea extracts and polyphenols, Mutation Res., 359, 159-163.
4. Balentine, D.A. (1994) Manufacturing and Chemistry of Tea, in C.-T. Ho, C.Y. Lee and M.-T. Huang (Eds.), Phenolic Compounds in Food and their Effects on Health I. ACS Symposium Series 506, American Chemical Society, Washington, DC, pp. 34-50.
5. Boobis, A.R., A.M. Lynch, S. Murray, R. de la Torre, A. Solans, M. Farre, J. Segura, N.J. Gooderham and D.S. Davies (1994) CYP1A2-catalysed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans, Cancer Res., 54, 89-94.
6. Buonarati, M.H. and J.S. Felton (1990), Activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to mutagenic metabolites, Carcinogenesis, 11, 1133-1138.
7. Chen, J. (1992) The antimutagenic and anticarcinogenic effects of tea, garlic and other natural foods in China: A review. Biomed. Environ. Sci., 5, 1-17.
8. Felton, J.S., M.G. Knize, N.H. Shen, P.R. Lewis, B.D. Andresen, J. Happe and F.T. Hatch (1986) The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Carcinogenesis, 7, 1081-1086.
9. Goodman, L.S., A. Gilman, J.G. Hardman, L.E. Limbird and E. Lee (1996) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn., McGraw Hill, New York.
10. Graham, H.N. (1992) Green tea composition, consumption and polyphenol chemistry, Prev. Med., 21, 334-350.
11. Hara, Y. (1994) Prophylactic functions of tea polyphenols, in: C.T. Ho, T. Osawa, M.T. Huang and T.R. Rosen (Eds.), Food Phytochemicals for Cancer Prevention II, Teas, Spices and Herbs, ACS Symposium Series 547, American Chemical Society, Washington, DC, pp. 34-50.
12. Hayatsu, H., N. Inada, T. Kakutani, S. Arimoto, T. Negishi, K. Mori, T. Okuda and I. Sakata (1992) Suppression of genotoxicity of carcinogenesis by (-)-epigallocatechin gallate, Prev. Med., 21, 370-376.
13. Hertog, G.L., E.J.M. Feskens, P.C.H. Hollman, M.B. Katan and D. Kromhout (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study, Lancet, 342, 1007-1011.
14. Huang, M.-T., C.-T. Ho, Z.Y. Wang, T. Ferraro, T. Finnegan-Olive, Y. Lou, J.M. Mitchell, J.D. Laskin, H. Newmark, C.S. Yang and A.H. Conney (1992) Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin, Carcinogenesis, 13, 947-954.
15. Imai, K. and K. Nakachi (1995) Cross sectional study of effects of drinking geen tea on cardiovascular and liver disease, Br. Med. J., 310, 692-696.
16. Ishikawa, T. (1992) The ATP-dependent glutathione S-conjugate export pump, Trends Biochem. Sci., 17, 463-468.
17. Katiyar, S.K. and H. Mukhtar (1996) Tea in chemoprevention of cancer: epidemiologic and experimental studies (review), Int. J. Oncol., 8, 221-238.
18. Kato, R. and Y. Yamazoe (1994) Metabolic activation of N-hydroxylated metabolites of carcinogenic and mutagenic arylamines and arylamides by esterification, Drug Metab. Rev., 26, 413-429.
19. Khan, S.G., S.K. Katiyar, R. Agarwal and H. Mukhtar (1992) Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention, Cancer Res., 52, 4050-4052.
20. Klaunig, J.E. (1992) Chemopreventive effects of green tea on hepatic components, Prev. Med., 21, 510-519.
21. Maron, D.M. and B.N. Ames (1983) Revised methods for the Salmonella mutagenicity test, Mutation Res., 113, 173-215.
22. Nagabushan, M., A.J. Amonkar, U.J. Nair, U. Santhanam, N. Ammigan, A.V. D'Souza and S.V. Bhide (1988) Catechin as an antimutagen: its mode of action, J. Cancer Res. Clin. Oncol., 114, 177-182.
23. Okushio, K., N. Matsumoto, M. Suzuki, F. Nanjo and Y. Hara (1995) Absorption of (-)- epigallocatechin gallate into rat portal vein, Biol. Pharm. Bull., 18(1), 190-191.
24. Prestera, T., Y. Zhang, S.R. Spencer, C.A. Wilczak and P. Talalay (1993) The electrophile counterattack response: protection against neoplasia and toxicity, Adv. Enzyme Regul., 33, 281-96.
25. Robertson, A. (1992) The chemistry and biochemistry of black tea production - the non-volatiles, in: K.C. Wilson and M.N. Clifford (Eds.), Tea: Cultivation to Consumption, Chapman and Hall, London, pp. 53-86.
26. Sebaldt, R.J. (1991) Figure Processor, User's Manual, Version 6.0, Biosoft, Cambridge, UK.
27. Sohn, O.S., A. Surace, E.S. Fiala, J.P. Richie, S. Colosimo, E. Zang and J.H. Weisburger (1994) Effects of green and black tea on hepatic xenobiotic metabolising systems in the male F344 rat, Xenobiotica, 24, 119-127.
28. Steele, C.M., M. Lalies and C. Ioannides (1985) Inhibition of the mutagenicity of aromatic amines by the plant flavonoid (+)-catechin, Cancer Res., 45, 3573-3577.
29. Symposium Proceedings (1992) Physiological and Pharmacological Effects of Camellia sinensis (Tea), Prev. Med., 21(3), 279-391 and 21(4), 395-553.
30. Unno, T. and T. Takeo (1995) Absorption of (-)-epigallocatechin gallate into the circulation system of rats, Biosci. Biotech. Biochem., 59, 1558-1559.
31. Wang, Z.Y. et al. (1988) Drug Metab. Dispos., 16, 98-103.
32. Wang, Z.Y, L.-D. Wang, M.-J. Lee, C.-T. Ho, M.-T. Huang, A.H. Conney and C.S. Yang (1995) Inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by green and black tea, Carcinogenesis, 16, 2143-2148.
33. Weisburger, J.H. (1996) Tea antioxidants and health, in: E. Cadenas and L. Packer (Eds.), Handbook of Antioxidants, Marcel Dekker, New York, pp. 469-486.
34. Xu, Y., C.T. Ho, S.G. Amin, C. Han and F.-L. Chung (1992) Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants, Cancer Res., 52, 3875-3879.
35. Yang, C.S. and Z.Y. Wang (1993) Tea and cancer, J. Natl. Cancer Inst., 85, 1038-1049.
36. Yu, G., C. Hsieh, L. Wang, S. Yu, X. Li and T. Jin (1995) Green tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China, Cancer Causes Control, 6, 532-538.